IOVANCE BIOTHERAPEUTICS, INC. Additional Paid in Capital, Common Stock
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Additional Paid in Capital, Common Stock of $87.61 million as of 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2014-11-13
- 2014-09-30: Additional Paid in Capital, Common Stock $87.61M.
- 2014-06-30: Additional Paid in Capital, Common Stock $86.03M.
- 2014-03-31: Additional Paid in Capital, Common Stock $83.35M.
- 2013-12-31: Additional Paid in Capital, Common Stock $81.88M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2014-09-30 | $87.61M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $86.03M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $83.35M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $81.88M 10-Q · filed 2014-11-13 | |
| 2013-09-30 | $40.58M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $31.74M 10-Q · filed 2013-10-23 | |
| 2013-03-31 | $19.21M 10-Q · filed 2013-10-23 | |
| 2012-12-31 | $19.12M 10-K · filed 2014-03-28 | $19.12M 10-K · filed 2013-09-23 |
| 2012-09-30 | $17.07M 10-Q · filed 2013-01-25 | |
| 2012-06-30 | $16.36M 10-Q/A · filed 2012-09-10 | |
| 2012-03-31 | $15.89M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $14.59M 10-K · filed 2013-09-23 | |
| 2011-09-30 | $13.33M 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $11.80M 10-Q/A · filed 2011-09-01 | |
| 2010-12-31 | $2.32M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |